Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer

NCT01677455 is registered in ClinicalTrials.gov with Synta Pharmaceuticals Corp. as lead sponsor.

NCT NCT01677455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01677455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer
Lead sponsor
Synta Pharmaceuticals Corp.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2012
Completion date
August 31, 2015
Enrollment
51 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, er/progressive response (pr) + refractory to prior hormonal treatment, her-2 positive breast cancer, triple negative breast cancer